# The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

> **NCT06424002** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Kamuzu University of Health Sciences** · enrollment: 5400 (estimated)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** Mosquirixs
- **DRUG:** artemether-lumefantrine

## Key facts

- **NCT ID:** NCT06424002
- **Lead sponsor:** Kamuzu University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2024-12-20
- **Final completion:** 2024-12-30
- **Target enrollment:** 5400 (ESTIMATED)
- **Last updated:** 2024-05-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06424002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06424002, "The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06424002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*